| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0074-7094-04 | 0074-7094 | HUMAN PRESCRIPTION DRUG | Qulipta | Atogepant | TABLET | ORAL | 20211006 | N/A | NDA | NDA215206 | AbbVie Inc. | ATOGEPANT | 60 mg/1 | 4 TABLET in 1 BOTTLE (0074-7094-04) |
| 0074-7094-30 | 0074-7094 | HUMAN PRESCRIPTION DRUG | Qulipta | Atogepant | TABLET | ORAL | 20210930 | N/A | NDA | NDA215206 | AbbVie Inc. | ATOGEPANT | 60 mg/1 | 30 TABLET in 1 BOTTLE (0074-7094-30) |
| 0074-7095-30 | 0074-7095 | HUMAN PRESCRIPTION DRUG | Qulipta | Atogepant | TABLET | ORAL | 20210930 | N/A | NDA | NDA215206 | AbbVie Inc. | ATOGEPANT | 10 mg/1 | 30 TABLET in 1 BOTTLE (0074-7095-30) |
| 0074-7096-04 | 0074-7096 | HUMAN PRESCRIPTION DRUG | Qulipta | Atogepant | TABLET | ORAL | 20211006 | N/A | NDA | NDA215206 | AbbVie Inc. | ATOGEPANT | 30 mg/1 | 4 TABLET in 1 BOTTLE (0074-7096-04) |
| 0074-7096-30 | 0074-7096 | HUMAN PRESCRIPTION DRUG | Qulipta | Atogepant | TABLET | ORAL | 20210930 | N/A | NDA | NDA215206 | AbbVie Inc. | ATOGEPANT | 30 mg/1 | 30 TABLET in 1 BOTTLE (0074-7096-30) |